NeoloMed BioSciences

NeoloMed Biosciences is a start-up biotechnology company based in New Jersey. We develop and commercialize new diagnostic products to support innovative bioscience research in oncology, immunology and stem cell technology. Our laboratory services focus on supporting the approval of new oncology drugs.

We are actively seeking partnerships with government agencies and private biotechnology firms for new opportunities to develop safer and more effective oncology drugs.

Our clients are pharmaceutical companies, biotechnology companies and non-profit institutions. We provide:

  • Stem cell toxicity assays
  • Tumor angiogenisis assays
  • Diagnostic kit development
  • Custom immuno-based and cell-based assays
  • Development of biomarkers relevant to oncology and stem cell research
  • Bioassay development consulting services